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Background/aim: To detect the effects on quinolone resistance due to biofilm formation activity in Ureaplasma urealyticum.
Materials and methods: An improved checkerboard dilution susceptibility test was used to analyze the quinolone resistance of clinical
Ureaplasma isolates and a postbiofilm formation susceptibility assay was used to compare the effects on the quinolone susceptibility
between pre- and postbiofilm formations. Several important functional gene expressions were detected to evaluate their roles in the
process of the quinolone resistance mechanism.
Results: The quinolone-resistant isolates produced more biofilms than the sensitive isolates. In both the quinolone-resistant and
-sensitive groups, the minimal inhibitory concentrations after biofilm formation were higher than those before biofilm formation. The
expression of the metabolism-related gene ureC in postbiofilm formation was higher than those in prebiofilm formation.
Conclusion: It seems that biofilm formation is quite important in the generation of quinolone resistance in Ureaplasma. It is very useful
to detect biofilm formation activity as well as to analyze other laboratory parameters for Ureaplasma.
Key words: Quinolone resistance, biofilm formation activity, Ureaplasma urealyticum

1.Introduction
Ureaplasma urealyticum is considered a part of the normal
genital flora in human beings. It is found in about 70% of
sexually active humans. It has also been associated with
a number of diseases, such as nonspecific urethritis (1),
infertility (2), or chorioamnionitis (3). The symptoms of U.
urealyticum infection are variable in different people and
bacterial strains (4). In addition, U. urealyticum has some
effects on other pathogen infections in the genital tract
and results in more complex mixed infections (5). Host–
pathogen interactions and adapted immune responses are
involved in the U. urealyticum infection processes, and
these features make for variable virulence and antibiotic
resistances in different populations (6).
Quinolone antibiotics are used widely to deal with
Ureaplasma infections. However, resistance to quinolone is
an increasingly serious problem in today’s clinical treatment
of this pathogen (7). The most important reason for this
* Correspondence: qingtianli@sjtu.edu.cn

situation is the improper uses of antibiotics. Furthermore,
according to the guidelines of the Clinical and Laboratory
Standards Institute (CLSI), the resistance or susceptibility of U.
urealyticum is judged by the ‘color change unit’. Unfortunately,
the current clinical susceptibility testing programs, based
on many commercial kits such as Mycoplasma IST2 kits
(bioMerieux, Marcy l’Etoile, France), cannot accurately
reflect the real resistance level of Ureaplasma.
In 2009, an available CLSI-compliance susceptibility
testing method was reported on by Beeton et al. (8). This
method made it possible to test the quantity of Ureaplasma
and the actual susceptibility of the organism. In this study,
we detected the biofilm formation of different Ureaplasma
strains, and then observed the Ureaplasma’s susceptibility
prebiofilm formation and postbiofilm formation. Some
functional gene expressions were evaluated to analyze
whether there was a correlation between these gene
expressions and biofilm formation in the pathogen.
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2. Materials and methods
2.1. Clinical Ureaplasma isolates and other reagents
Sixty-nine Ureaplasma isolates were collected from the
Department of Urology and Genecology of Ruijin Hospital,
Shanghai Jiao Tong University School of Medicine from
June to November 2009. Mycoplasma IST2 kits were
purchased from bioMerieux. Antibiotics ciprofloxacin
and ofloxacin were sourced from Sigma Chemical Co.
(St Louis, MO, USA). Ureaplasma media were purchased
from Livzon Inc. (Zhuhai, China). Gene extraction and
real-time polymerase chain reaction (PCR) kits were
purchased from Tiagen Biotech Co., Ltd. (Beijing, China).
2.2. Ureaplasma susceptibility test
Ureaplasma susceptibility was detected by the improved
checkerboard dilution method as described by Beeton
et al. (8). Antibiotics ciprofloxacin and ofloxacin were
used in the susceptibility test. In 96-well plates, 180 µL of
ciprofloxacin and of ofloxacin was added in different wells,
with concentrations ranging from 16 µg/mL to 0.25 µg/
mL for ciprofloxacin and from 32 µg/mL to 0.5 µg/mL for
ofloxacin, changing by 2-fold serial dilutions. Thereafter,
20-µL Ureaplasma samples were added to the test wells.
Another dilution gradient was the Ureaplasma sample
itself without antibiotics. This nonantibiotic control group
was used to identify the initial sample sizes. Based on
the minimal inhibitory concentrations (MICs) of these
2 antibiotics, the isolates were divided into 2 groups: a
quinolone-sensitive group and a quinolone-resistant
group. Only when the MIC was ≥2 µg/mL for ciprofloxacin
and ≥4 µg/mL for ofloxacin were isolates classified as
quinolone-resistant; Ureaplasma isolates were determined
as sensitive when the MIC was ≤1 µg/mL for ciprofloxacin
and ≤2 µg/mL for ofloxacin.
2.3. Biofilm formation and postbiofilm formation
susceptibility assays
For the bacterial biofilm formation test, sterile Teflon
membranes (9,10) were immersed into the Ureaplasma
media and incubated at 37 °C. After the media changed
from orange to fuchsia, these membranes were washed
twice with sterile phosphate-buffered saline and removed
to the second Ureaplasma culture, and total protein
was analyzed. The biofilm formation ability was then
determined by the second culture time (the medium color
change time) and the protein volume was detected by a
classical Coomassie Brilliant Blue stain method with the
optical density read at 570 nm.
Postbiofilm formation susceptibility assays were
performed as previously described (11) and a comparison
was made between the susceptibility of pre- and postbiofilm
formation based on the previously improved checkerboard
dilution method. Ofloxacin was used in these postbiofilm
formation susceptibility tests. All tests were performed in
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duplicate and results are expressed as the mean value of
both experiments.
2.4. Biofilm formation and multiple functional gene
expression of U. urealyticum
Several key gene expressions were detected by q-PCR
in this study. They were the virulence-related gene
mba, the metabolism-related gene ureC, and the
quinolone resistance-related gene gyrA. The q-PCR
primers were: mba (ACCTACACCAACTCCTGA,
TCTTGTAATTCTTGAGTAT),
ureC
( A G C G T TA G AT TA G G A G A C A C ,
C A T T A C T T C A G C A T T C C C ) ,
gyrA
(ATGGCGTTAAAAAAACC,
TGCTCTTCGATGTACAGG),
and
the
control
16S
rDNA
(TCGTGTCGTGAGATGTTGGGTTA,
GGTTTCGCTGCCCTTTGTATTGT).
An
Applied
Biosystems ABI 7500 Fast Real-Time PCR System and
the standard q-PCR procedure were used for the q-PCR
amplifications in this study. The ratios of postbiofilm
expression to prebiofilm expression were calculated, and
ratios of >2.0 or <0.5 mean increased or decreased gene
expression, respectively.
2.5. Statistical analysis
The significance of the differences between the means
was analyzed by double-sided Student’s t-test, and other
data were analyzed by the chi-square test. P < 0.05 was
considered significant.
3. Results
In this study, the isolates resistant to both ciprofloxacin and
ofloxacin were considered as quinolone-resistant strains,
and those susceptible to both antibiotics were considered
as quinolone-susceptible. Of the 69 Ureaplasma isolates,
there were 42 isolates that were determined as quinoloneresistant and 27 as quinolone-sensitive (Table 1).
The biofilm formation activity was determined by
the secondary culture time to the media color change
and the biofilm total protein quantitation (Figure 1). The
secondary culture time of the isolates in the resistant group
was significant lower than that in the sensitive group (P <
0.05). At the same time, the biofilm total protein volume
in the resistant group was much higher than that in the
sensitive group (P < 0.05). These results showed that the
Ureaplasma isolates in the resistant group could produce
more biofilm than the sensitive isolates.
Another classical biofilm susceptibility test (11) was
performed on these 2 groups of Ureaplasma (Figure 2).
Compared with the MIC before biofilm formation, the
MIC after biofilm formation was increased significantly
in the isolates in the resistant and sensitive groups. It
seems that biofilm formation can improve the resistance
to ofloxacin in U. urealyticum.
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Table 1. Minimal inhibitory concentrations of ciprofloxacin and ofloxacin in 69 Ureaplasma urealyticum isolates.
Number of isolates (MIC of ciprofloxacin, µg/mL)
≥16

Number of
isolates (MIC of
ofloxacin, µg/mL)

≥32

1

16

1

8

4

2

6

1

11

18

1

8

2

4
2

2

1

6

(A)
*

10

5

Sensitive (n = 27)

Biofilm total protein quantitation (OD)

Secondary culture time (h)

20

Resistant (n = 42)

14
4

15

≤0.25

2

≤0.5

0

0.5

1

1.0

(B)

0.8
0.6
0.4
*
0.2
0.0

Resistant (n = 42)

Sensitive (n = 27)

Figure 1. The biofilm formation activities of quinolone-resistant and -sensitive U. urealyticum. (A) The secondary culture time of
quinolone-resistant and -sensitive Ureaplasma. The biofilm was produced on sterile Teflon membranes; then the free bacteria were
discarded and the membranes were cultured in Mycoplasma IST2 media and the secondary culture time was calculated. (B) The
biofilm total protein quantitation of quinolone-resistant and -sensitive Ureaplasma. The Teflon membranes were stained and the
optical densities at 570 nm were recorded. * = Significant difference compared to resistant groups, P < 0.05.

Ofloxacin MIC (µg/mL)

15

*

10

5

0

*

pre-MIC
(resistant)

post-MIC
(resistant)

pre-MIC
(sensitive)

post-MIC
(sensitive)

Figure 2. The ofloxacin MIC (µg/mL) of quinolone-resistant and
-sensitive Ureaplasma before (pre-MIC) and after (post-MIC)
biofilm was produced. The improved checkerboard dilution
method was used to analyze the ofloxacin MIC (µg/mL). * =
Significant difference compared to pre-MIC, P < 0.05.

The expressions of virulence-, metabolism-, and
quinolone resistance-related genes mba, ureC, and
gyrA were detected and compared between prebiofilm
formation and postbiofilm formation in this study. ureC
gene expression was increased at postbiofilm formation
compared with prebiofilm formation; however, there were
no significant differences in the other genes’ expressions
between pre- and postbiofilm formation (Table 2).
4. Discussion
Ureaplasma urealyticum is a bacterium that is related to
several diseases and can be passed through sexual contact,
although it is not a classic STI or STD (12,13). At present, 3
types of antibiotics are used in the treatment of Ureaplasma.
They are tetracyclines (14), macrolides (15), and
quinolones (16). The rates of resistance to fluoroquinolones
(ofloxacin, ciprofloxacin) have been >50% since 1999 (17).
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Table 2. Multiple functional gene expressions in quinolone resistant and sensitive U. urealyticum.

Gene

mba
(ratio of postbiofilm expression
to prebiofilm expression)

ureC
(ratio of postbiofilm expression
to prebiofilm expression)

gyrA
(ratio of postbiofilm expression to
prebiofilm expression)

Resistant (n = 42)

0.83 ± 0.12

4.72 ± 2.58 *

0.94 ± 0.09

Sensitive (n = 27)

1.05 ± 0.17

2.49 ± 0.84 *

1.24 ± 0.13

*: P < 0.05.

To date, the current clinical Ureaplasma susceptibility
test is colorimetry using Mycoplasma IST2 produced by
bioMerieux. However, the initial actual amount is not
considered in this method, so this method is not in full
compliance with the CLSI criteria (18).
Ureaplasma is known to produce biofilms, which could
trap inflammatory products and thereby mechanically
block inflammatory signaling (19). In our study, secondary
culture time was used to evaluate the biofilm formation
activities of isolates in 2 groups. The secondary culture
time of the isolates in the resistant group was much shorter
than the time of those in the sensitive group. At the same
time, the optical density value of the total protein detection
of the isolates in the resistant group was much higher than
that in the sensitive group. These results illustrated that
quinolone-resistant Ureaplasma isolates created more
biofilms than quinolone-sensitive isolates, which means
that the quinolone resistance features of Ureaplasma may
be related to the biofilm formation of this pathogen.
After the biofilm formation, higher ofloxacin MIC
values were detected in both quinolone-resistant
Ureaplasma and quinolone-sensitive Ureaplasma.
The barrier function may be the major reason for the
higher quinolone resistance in those postformation
Ureaplasma strains. It is noteworthy that after the biofilm
formation, some of the sensitive Ureaplasma isolates

“transformed” to resistant isolates, as determined by the
improved checkerboard dilution method for Ureaplasma
susceptibility analysis. More attention should be paid to
this situation in order to improve clinical efficacy and
prevent the development of drug resistance.
Higher expressions of the metabolism-related gene
ureC were found in postbiofilm formation than in
prebiofilm formation, which was not the case for the
virulence- and quinolone resistance-related genes mba
and gyrA. This improved ureC expression might be due to
the physical barrier that disturbs the nutrient acquisition
of this pathogen.
In conclusion, the biofilm formation activity
in Ureaplasma might affect the clinical antibiotic
susceptibility tests and the treatment efficacy, and even
lead to the emergence and development of drug resistance.
It is extremely valuable to add biofilm formation tests to
the laboratory analyses for Ureaplasma.
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